Considerations in the testing of a minimum viable product in healthcare

Abstract

Introducing a Minimum Viable Product in the market and rapidly testing it proves valuable in assessing its value and potential. This involves experiments, gauging growth, and striving to diminish uncertainty in iterative cycles. The application of these approaches in healthcare, however, faces obstacles due to unique challenges including patient safety concerns and regulatory compliances. This paper undertakes a narrative literature review covering experiences of healthcare professionals and presents guiding considerations for medical startups to use in the market validation of their products.